Dr. Huang Kaisheng, Chief Operating Officer of the company, has achieved considerable success, as demonstrated by his outstanding achievements in the fields of biopharmaceutical R&D, production, quality control, and registration application. He has led or participated in the IND or BLA application for more than a dozen new drugs. He joined RemeGen in 2019 and is in charge of the company’s GMP quality system and CMC compliance. He is committed to promoting the internationalization of domestic biopharmaceuticals and is the person in charge of pharmacy of Telitacicept. He received his Phd in Medicinal Chemistry from the Union Medical College of China, and completed postdoctoral research at the Institute of Biochemistry at Washington State University.